Herbal preparations for the treatment of hair loss

  • Ana Zgonc Škulj
  • Nina PoljšakEmail author
  • Nina Kočevar Glavač
  • Samo Kreft


Though hair does not serve any crucial physiological function in modern humans, it plays an important role in our self-esteem. Androgenic baldness (androgenic alopecia) and circular/spot baldness (alopecia areata) are the most common forms of hair loss. Many active ingredients of synthetic origin are available for treatment; however, they have a number of limitations. Their effectiveness and safety are questionable and the amount of time needed to achieve the effect is both long and unclear. This has increased interest in finding an alternative approach against hair loss using preparations containing plants and/or their isolated active ingredients. A number of studies (mostly randomized, placebo-controlled) of plants and preparations made of plants have been performed to confirm their effectiveness in treating hair loss. The plants with the most evidence-based effect against alopecia are Curcuma aeruginosa (pink and blue ginger), Serenoa repens (palmetto), Cucurbita pepo (pumpkin), Trifolium pratense (red clover), and Panax ginseng (Chinese red ginseng). The assumed mechanism of action is predominately inhibition of 5α-reductase, with enhanced nutritional support and scalp blood circulation playing a role as well.


Alopecia Androgenic baldness Circular baldness Hair loss Herbal preparations 


Author contributions

A.Z.Š. and S.K. conceived of the review article idea. A.Z.Š. and N.P. selected and reviewed the literature. S.K. encouraged A.Z.Š. and N.P. to investigate the article’s topic and supervised the findings A.Z.Š. and N.P. made substantial contributions to the conception and design of the article. N.P. prepared an English translation of the article. N.K.G. and S.K. participated in drafting the article and revised it critically for important intellectual content. All authors have read and approved the final manuscript.


There were no sources of funding for this manuscript.

Compliance with ethical standards

Conflict of interest

Authors declare no conflicts of interest.


  1. 1.
    Hunt N, McHale S (2005) The psychological impact of alopecia. BMJ 331:951–953. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Draelos ZK, Pugliese PT (2011) Physiology of the skin. Allured Business Media, Carol StreamGoogle Scholar
  3. 3.
    Zviak C (1986) Hair structure, function and physicochemical properties. The Science of Hair Carel. Marcel Dekker Inc, New York, pp 1–44CrossRefGoogle Scholar
  4. 4.
    Stenn KS, Paus R (2001) Controls of hair follicle cycling. Physiol Rev 81:449–494. CrossRefPubMedGoogle Scholar
  5. 5.
    Hardy MH (1992) The secret life of the hair follicle. Trends Genet 8:55–61. CrossRefPubMedGoogle Scholar
  6. 6.
    Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341:491–497. CrossRefPubMedGoogle Scholar
  7. 7.
    Sasaki GH (2019) Review of human hair follicle biology: dynamics of niches and stem cell regulation for possible therapeutic hair stimulation for plastic surgeons. Aesthetic Plast Surg 43:253–266. CrossRefPubMedGoogle Scholar
  8. 8.
    Rook A (1965) Endocrine influences on hair growth. BMJ 1:609–614. CrossRefPubMedGoogle Scholar
  9. 9.
    Trüeb RM (2002) Molecular mechanisms of androgenetic alopecia. Exp Gerontol 37:981–990. CrossRefPubMedGoogle Scholar
  10. 10.
    El-Domyati M, Attia S, Saleh F, Abdel-Wahab H (2009) Androgenetic alopecia in males: a histopathological and ultrastructural study. J Cosmet Dermatol 8:83–91. CrossRefPubMedGoogle Scholar
  11. 11.
    Hibino T, Nishiyama T (2004) Role of TGF-beta2 in the human hair cycle. J Dermatol Sci 35:9–18. CrossRefPubMedGoogle Scholar
  12. 12.
    Li AG, Lu S-L, Han G et al (2006) Role of TGFβ in skin inflammation and carcinogenesis. Mol Carcinog 45:389–396. CrossRefPubMedGoogle Scholar
  13. 13.
    Huh S, Lee J, Jung E et al (2009) A cell-based system for screening hair growth-promoting agents. Arch Dermatol Res 301:381–385. CrossRefPubMedGoogle Scholar
  14. 14.
    Inui S, Fukuzato Y, Nakajima T et al (2002) Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth. FASEB J 16:1967–1969. CrossRefPubMedGoogle Scholar
  15. 15.
    Thigpen AE, Davis DL, Milatovich A et al (1992) Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 90:799–809. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hoffmann R, Happle R (2000) Current understanding of androgenetic alopecia. Part I: Etiopathogenesis. Eur J Dermatol 10:319–327PubMedGoogle Scholar
  17. 17.
    Blumeyer A, Tosti A, Messenger A et al (2011) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 9(Suppl 6):S1–57. CrossRefPubMedGoogle Scholar
  18. 18.
    Meidan VM, Touitou E (2001) Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. Drugs 61:53–69. CrossRefPubMedGoogle Scholar
  19. 19.
    Abell E, Munro DD (2006) Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 88:55–60. CrossRefGoogle Scholar
  20. 20.
    Kaushik R, Gupta D, Yadav R (2011) Alopecia: herbal remedies. Int J Pharm Sci Res 2:1631–1637.
  21. 21.
    Vishal L, Chandrakant S, Amit S et al (2017) Androgenic alopecia: current perspectives and treatments. World J Pharm Pharm Sci 6:641–653.
  22. 22.
    Hajheydari Z, Jamshidi M, Akbari J, Mohammadpour R (2007) Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: a double-blind randomized controlled study. Indian J Dermatol Venereol Leprol 73:29–32. CrossRefPubMedGoogle Scholar
  23. 23.
    Guercio V, Galeone C, Turati F, La Vecchia C (2014) Gastric cancer and allium vegetable intake: a critical review of the experimental and epidemiologic evidence. Nutr Cancer 66:757–773. CrossRefPubMedGoogle Scholar
  24. 24.
    Hill ND, Bunata K, Hebert AA (2015) Treatment of alopecia areata with squaric acid dibutylester. Clin Dermatol 33:300–304. CrossRefPubMedGoogle Scholar
  25. 25.
    Al-Kayssi B (1991) Re-evaluation of conventional therapies in alopecia areata. University of Baghdad, College of MedicineGoogle Scholar
  26. 26.
    Lee SW, Trapnell BC, Rade JJ et al (1993) In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 73:797–807. CrossRefPubMedGoogle Scholar
  27. 27.
    Sharquie KE, Al-Obaidi HK (2002) Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. J Dermatol 29:343–346. CrossRefPubMedGoogle Scholar
  28. 28.
    Sharangi AB (2009) Medicinal and therapeutic potentialities of tea (Camellia sinensis L.)—a review. Food Res Int 42:529–535. CrossRefGoogle Scholar
  29. 29.
    Proniuk S, Liederer BM, Blanchard J (2002) Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci 91:111–116. CrossRefPubMedGoogle Scholar
  30. 30.
    Hsu S, Bollag WB, Lewis J et al (2003) Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J Pharmacol Exp Ther 306:29–34. CrossRefPubMedGoogle Scholar
  31. 31.
    Hiipakka RA, Zhang H-Z, Dai W et al (2002) Structure–activity relationships for inhibition of human 5α-reductases by polyphenols. Biochem Pharmacol 63:1165–1176. CrossRefPubMedGoogle Scholar
  32. 32.
    Kwon OS, Han JH, Yoo HG et al (2007) Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine 14:551–555. CrossRefPubMedGoogle Scholar
  33. 33.
    Esfandiari A, Kelly AP (2005) The effects of tea polyphenolic compounds on hair loss among rodents. J Natl Med Assoc 97:1165–1169PubMedPubMedCentralGoogle Scholar
  34. 34.
    Zambo I (1988) Analytical standardization of peponen. In: Mediflora. pp 89, 6Google Scholar
  35. 35.
    Hong H, Kim C-S, Maeng S (2009) Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract 3:323–327. CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Gossell-Williams M, Davis A, O’Connor N (2006) Inhibition of testosterone-induced hyperplasia of the prostate of Sprague-Dawley rats by pumpkin seed oil. J Med Food 9:284–286. CrossRefPubMedGoogle Scholar
  37. 37.
    Carbin B-E, Larsson B, Lindahl O (1990) Treatment of Benign prostatic hyperplasia with phytosterols. Br J Urol 66:639–641. CrossRefPubMedGoogle Scholar
  38. 38.
    Cho YH, Lee SY, Jeong DW et al (2014) Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial. Evidence Based Complement Altern Med 2014:7. CrossRefGoogle Scholar
  39. 39.
    Perry LM, Metzger J (2014) Medicinal plants of east and Southeast Asia: attributed properties and uses. MIT Press, CambridgeGoogle Scholar
  40. 40.
    Jantan I, Yassin MSM, Chin CB et al (2003) Antifungal activity of the essential oils of nine Zingiberaceae species. Pharm Biol 41:392–397. CrossRefGoogle Scholar
  41. 41.
    Pumthong G, Asawanonda P, Varothai S et al (2012) Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study. J Dermatolog Treat 23:385–392. CrossRefPubMedGoogle Scholar
  42. 42.
    Srivilai J, Nontakhot K, Nutuan T et al (2018) Sesquiterpene-Enriched Extract of Curcuma aeruginosa Roxb. Retards axillary hair growth: a randomised, placebo-controlled double-blind study. Skin Pharmacol Physiol 31:99–106. CrossRefPubMedGoogle Scholar
  43. 43.
    Dũng NX, Tuyêt NTB, Leclercq PA (1995) Characterization of the Leaf Oil of Curcuma aeruginosa Roxb. from Vietnam. J Essent Oil Res 7:657–659. CrossRefGoogle Scholar
  44. 44.
    Makabe H, Maru N, Kuwabara A et al (2006) Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res 20:680–685. CrossRefPubMedGoogle Scholar
  45. 45.
    Suphrom N, Pumthong G, Khorana N et al (2012) Anti-androgenic effect of sesquiterpenes isolated from the rhizomes of Curcuma aeruginosa Roxb. Fitoterapia 83:864–871. CrossRefPubMedGoogle Scholar
  46. 46.
    Srivilai J, Phimnuan P, Jaisabai J et al (2017) Curcuma aeruginosa Roxb. essential oil slows hair-growth and lightens skin in axillae; a randomised, double blinded trial. Phytomedicine 25:29–38. CrossRefPubMedGoogle Scholar
  47. 47.
    Srivilai J, Waranuch N, Tangsumranjit A et al (2018) Germacrone and sesquiterpene-enriched extracts from Curcuma aeruginosa Roxb. increase skin penetration of minoxidil, a hair growth promoter. Drug Deliv Transl Res 8:140–149. CrossRefPubMedGoogle Scholar
  48. 48.
    Chang HK (1998) The pharmacology of Chinese Herbs, 2nd edn. CRC Press, Boca RatonGoogle Scholar
  49. 49.
    Matsuura H, Hirao Y, Yoshida S et al (1984) Study of red ginseng: new glucosides and a note on the occurrence of maltol. Chem Pharm Bull (Tokyo) 32:4674–4677. CrossRefGoogle Scholar
  50. 50.
    Kitagawa I, Yoshikawa M, Yoshihara M et al (1983) Chemical Studies on Crude Drug Precession. I. On the Constituents of Ginseng Radix Rubra (1). Yakugaku Zasshi 103:612–622. CrossRefPubMedGoogle Scholar
  51. 51.
    Kim J-H, Yi S-M, Choi J-E, Son S-W (2009) Study of the efficacy of Korean red ginseng in the treatment of androgenic alopecia. J Ginseng Res 33:223–228. CrossRefGoogle Scholar
  52. 52.
    Attele AS, Wu JA, Yuan CS (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58:1685–1693. CrossRefPubMedGoogle Scholar
  53. 53.
    He B-C, Gao J-L, Luo X et al (2011) Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/β-catenin signaling. Int J Oncol. CrossRefPubMedGoogle Scholar
  54. 54.
    Kang J-H, Song K-H, Woo J-K et al (2011) Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulation of the IGF-1R/Akt pathway in breast cancer cells. Plant Foods Hum Nutr 66:298–305. CrossRefPubMedGoogle Scholar
  55. 55.
    Matsuda H, Yamazaki M, Asanuma Y, Kubo M (2003) Promotion of hair growth by ginseng radix on cultured mouse vibrissal hair follicles. Phyther Res 17:797–800. CrossRefGoogle Scholar
  56. 56.
    Oh GN, Son SW (2012) Efficacy of Korean red ginseng in the treatment of alopecia areata. J Ginseng Res 36:391–395. CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Park G-H, Park K, Cho H et al (2015) Red Ginseng extract promotes the hair growth in cultured human hair follicles. J Med Food 18:354–362. CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Kim SH, Jeong KS, Ryu SY, Kim TH (1998) Panax ginseng prevents apoptosis in hair follicles and accelerates recovery of hair medullary cells in irradiated mice. Vivo 12:219–222Google Scholar
  59. 59.
    Park E-K, Choo M-K, Han MJ, Kim D-H (2004) Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 133:113–120. CrossRefPubMedGoogle Scholar
  60. 60.
    Rossi A, Mari E, Scarno M et al (2012) Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol 25:1167–1173. CrossRefPubMedGoogle Scholar
  61. 61.
    Sinclair RD, Mallari RS, Tate B (2002) Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. Australas J Dermatol 43:311–312. CrossRefPubMedGoogle Scholar
  62. 62.
    Prager N, Bickett K, French N, Marcovici G (2002) A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 8:143–152. CrossRefPubMedGoogle Scholar
  63. 63.
    Murugusundram S (2009) Serenoa repens: does it have any role in the management of androgenetic alopecia? J Cutan Aesthet Surg 2:31–32. CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T (1999) Antibacterial and antiandrogen flavonoids from Sophora flavescens. J Nat Prod 62:1595–1599. CrossRefPubMedGoogle Scholar
  65. 65.
    Yamahara J, Kobayashi G, Iwamoto M et al (1990) Vasodilatory active principles of Sophora flavescens root. J Ethnopharmacol 29:79–85. CrossRefPubMedGoogle Scholar
  66. 66.
    Ko WG, Kang TH, Kim NY et al (2000) Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens. Toxicol In Vitro 14:429–433. CrossRefPubMedGoogle Scholar
  67. 67.
    Werner S, Smola H, Liao X et al (1994) The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266:819–822. CrossRefPubMedGoogle Scholar
  68. 68.
    Philpott MP, Green MR, Kealey T (1990) Human hair growth in vitro. J Cell Sci 97(Pt 3):463–471PubMedGoogle Scholar
  69. 69.
    Roh S-S, Kim CD, Lee M-H et al (2002) The hair growth promoting effect of Sophora flavescens extract and its molecular regulation. J Dermatol Sci 30:43–49CrossRefGoogle Scholar
  70. 70.
    Takahashi T, Ishino A, Arai T et al (2016) Improvement of androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active compounds in the extract that stimulate proliferation of human hair keratinocytes. Clin Exp Dermatol 41:302–307. CrossRefPubMedGoogle Scholar
  71. 71.
    Gao X, Wang W, Wei S, Li W (2009) Review of pharmacological effects of Glycyrrhiza radix and its bioactive compounds. Zhongguo Zhong Yao Za Zhi 34:2695–2700. CrossRefPubMedGoogle Scholar
  72. 72.
    Loing E, Lachance R, Ollier V, Hocquaux M (2013) A new strategy to modulate alopecia using a combination of two specific and unique ingredients. J Cosmet Sci 64:45–58PubMedGoogle Scholar
  73. 73.
    Schweiger ES, Boychenko O, Bernstein RM (2010) Update on the pathogenesis, genetics and medical treatment of patterned hair loss. J Drugs Dermatol 9:1412–1419PubMedGoogle Scholar
  74. 74.
    Hay IC, Jamieson M, Ormerod AD (1998) Randomized trial of aromatherapy. Successful treatment for alopecia areata. Arch Dermatol 134:1349–1352. CrossRefPubMedGoogle Scholar
  75. 75.
    Bureau JP, Ginouves P, Guilbaud J, Roux ME (2003) Essential oils and low-intensity electromagnetic pulses in the treatment of androgen-dependent alopecia. Adv Ther 20:220–229. CrossRefPubMedGoogle Scholar
  76. 76.
    Maddin WS, Bell PW, James JH (1990) The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis. Int J Dermatol 29:446–450. CrossRefPubMedGoogle Scholar
  77. 77.
    Maddin WS, Amara I, Sollecito WA (1992) Electrotrichogenesis: further evidence of efficacy and safety on extended use. Int J Dermatol 31:878–880. CrossRefPubMedGoogle Scholar
  78. 78.
    Herman A, Herman AP (2015) Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol 67:473–485. CrossRefPubMedGoogle Scholar
  79. 79.
    Boutekedjiret C, Bentahar F, Belabbes R, Bessiere JM (2003) Extraction of rosemary essential oil by steam distillation and hydrodistillation. Flavour Fragr J 18:481–484. CrossRefGoogle Scholar
  80. 80.
    Al-Sereiti MR, Abu-Amer KM, Sen P (1999) Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130. CrossRefPubMedGoogle Scholar
  81. 81.
    Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A (2015) Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed 13:15–21PubMedGoogle Scholar
  82. 82.
    Vennat B, Bos MA, Pourrat A, Bastide P (1994) Procyanidins from tormentil: fractionation and study of the anti-radical activity towards superoxide anion. Biol Pharm Bull 17:1613–1615. CrossRefPubMedGoogle Scholar
  83. 83.
    Haslam E (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod 59:205–215. CrossRefPubMedGoogle Scholar
  84. 84.
    Shoji O, Kunimatsu T, Kawakami N, Watanabe Y (2013) Highly selective hydroxylation of benzene to phenol by wild-type cytochrome P450BM3 assisted by decoy molecules. Angew Chem Int Ed Engl 52:6606–6610. CrossRefPubMedGoogle Scholar
  85. 85.
    Takahashi T, Kamimura A, Kagoura M et al (2005) Investigation of the topical application of procyanidin oligomers from apples to identify their potential use as a hair-growing agent. J Cosmet Dermatol 4:245–249. CrossRefPubMedGoogle Scholar
  86. 86.
    Soma T, Tsuji Y, Hibino T (2002) Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle. J Invest Dermatol 118:993–997. CrossRefPubMedGoogle Scholar
  87. 87.
    Foitzik K, Lindner G, Mueller-Roever S et al (2000) Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J 14:752–760. CrossRefPubMedGoogle Scholar
  88. 88.
    Jaworsky C, Kligman AM, Murphy GF (1992) Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol 127:239–246. CrossRefPubMedGoogle Scholar
  89. 89.
    Sueki H, Stoudemayer T, Kligman AM, Murphy GF (1999) Quantitative and ultrastructural analysis of inflammatory infiltrates in male pattern alopecia. Acta Derm Venereol 79:347–350. CrossRefPubMedGoogle Scholar
  90. 90.
    Takahashi T, Kamiya T, Yokoo Y (1998) Proanthocyanidins from grape seeds promote proliferation of mouse hair follicle cells in vitro and convert hair cycle in vivo. Acta Derm Venereol 78:428–432. CrossRefPubMedGoogle Scholar
  91. 91.
    Kamimura A, Takahashi T (2002) Procyanidin B-3, isolated from barley and identified as a hair-growth stimulant, has the potential to counteract inhibitory regulation by TGF-beta1. Exp Dermatol 11:532–541. CrossRefPubMedGoogle Scholar
  92. 92.
    Kamimura A, Takahashi T, Watanabe Y (2000) Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. Phytomedicine 7:529–536. CrossRefPubMedGoogle Scholar
  93. 93.
    Guo EL, Katta R (2017) Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept 7:1–10. CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Smith RP, Coward RM, Kovac JR, Lipshultz LI (2013) The evidence for seasonal variations of testosterone in men. Maturitas 74:208–212. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Faculty of PharmacyUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations